MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • MDS Virtual Congress 2020

    Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic

    C. Taylor, C. Johnson, J. Marsh, L. Brown, A. Silverwood, R. Stringer, C. Cooper, R. Skelly (Derby, United Kingdom)

    Objective: The overall aim of the project was to demonstrate that people with Parkinson’s disease benefit from good mental health care when mental health services…
  • MDS Virtual Congress 2020

    Clinical outcomes after DBS surgery in cognitively impaired patients with PD

    M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)

    Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…
  • MDS Virtual Congress 2020

    Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia

    K. Ohta, T. Nakajima (Kashiwazaki city Niigata, Japan)

    Objective: The clinical and neuroimaging factors associated with dysphagia were investigated in this retrospective data of Parkinson's disease (PD) patients. Background: PD can cause dysphagia…
  • MDS Virtual Congress 2020

    Does age at onset of Parkinson’s disease affect the development of dementia?

    P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)

    Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…
  • MDS Virtual Congress 2020

    Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

    Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)

    Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…
  • MDS Virtual Congress 2020

    Predictors of transfer to facility or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

    Y. Higashi, M. Tabata (Himeji, Japan)

    Objective: To investigate the reasons for hospital admissions for Parkinson's disease (PD) patients and to determine the predictors of transfer to facility or nursing home…
  • MDS Virtual Congress 2020

    Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease

    Y.L Tang, LL. Han, F. Huang, J. Wang (Shanghai, China)

    Objective: To examine whether miRNA-29s (miR-29s) in serum could be used as biomarkers for either Parkinson’s disease with dementia (PDD) or Parkinson’s disease with mild…
  • MDS Virtual Congress 2020

    Quantitative method for designing appropriate longitudinal follow-up frequency with application to Parkinson’s disease cognition research

    L. Suttner, S. Xie (Philadelphia, PA, USA)

    Objective: To develop a quantitative method for designing appropriate longitudinal follow-up frequency. We demonstrate how to use this new method using a progression study of…
  • MDS Virtual Congress 2020

    Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus

    Q. Wang (Guangzhou, China)

    Objective: Identifying the risk factors of dementia in patients with both Parkinson’s disease (PD) and type 2 diabetes mellitus (DM) (PD-DM) is clinically relevant and…
  • MDS Virtual Congress 2020

    Prion disease with 8 octapeptide repeat insertional mutation presenting with HDL1 phenotype

    C. Cooper, D. Hall, B. Fogel, H. Lee, U. Diseases Network (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a patient with an insertion of 8 extra octapeptide repeats in the prion protein gene (PRNP).…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley